keyword
https://read.qxmd.com/read/38646905/pharmacotherapy-considerations-for-patients-who-develop-acute-kidney-injury-during-cancer-therapy
#1
REVIEW
Emanuele Parodi, Maura Rossi, Achille Bottiglieri, Marco Ladetto, Guido Merlotti, Vincenzo Cantaluppi, Marco Quaglia
INTRODUCTION: Acute kidney injury (AKI) frequently develops in patients receiving cancer therapy and requires a wide differential diagnosis due to possible role of unique cancer and drug-related factors, in addition to common pre- and post-renal causes. Rapid development of new molecular targeted anti-cancer drugs and immunotherapies has opened unprecedented possibilities of treatment at the price of an increased spectrum of renal side effects. AREAS COVERED: The present review aims at providing a state-of-the-art picture of AKI in cancer patient (PubMed and Embase libraries were searched from inception to January 2024), with a focus on differential diagnosis and management of diverse clinical settings...
April 22, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38634072/the-impact-of-comorbidity-on-the-quality-of-life-of-people-who-recovered-from-covid-19-in-bangladesh
#2
JOURNAL ARTICLE
Md Abdullah Saeed Khan, Koustuv Dalal, Mehedi Hasan, Miah Md Akiful Haque, Nusrat-E-Mozid, Mosharop Hossian, Tajrin Rahman, Ramisha Maliha, Archi Mutsuddi, Md Utba Rashid, Mohammad Ali Hossain, Mohammad Hayatun Nabi, Mohammad Delwer Hossain Hawlader
OBJECTIVES: COVID-19 affects the quality of life (QoL) in a reverse way after recovery, which might be multiplied by the comorbid non-communicable diseases. This study explored the relationship between comorbidities and the QoL of people who recovered from COVID-19 in Bangladesh. METHODS: The cross-sectional study was conducted among 3244 participants between June 2020 and November 2020 using a pre-tested questionnaire through over-the-phone interviews. The WHOQOL-BREF was used to explore the QoL among the study participants...
June 2024: IJID Reg
https://read.qxmd.com/read/38633010/the-effect-of-vaccination-with-pfizer-biontech-or-coronavac-on-disease-prognosis-among-hospitalized-covid-19-patients
#3
JOURNAL ARTICLE
Mustafa Güldan, Sena Tuğana Ateş, Sebile Sarıoğlu, Sarp Suyabatmaz, Pelin İrkören, Süda Tekin, Mahir Kapmaz, Şiran Keske, Önder Ergönül
OBJECTIVE: The Turkish Ministry of Health offered two types of vaccines by January 13, 2021, which are CoronaVac (Sinovac Biotech, China) and Pfizer-BioNTech. We aimed to describe the impact of the CoronaVac and Pfizer-BioNTech vaccines on clinical outcomes among hospitalized patients during a six-month period. METHODS: We included patients older than 18 years old and hospitalized because of COVID-19 when the vaccines were available. We conducted the study at Koç University Hospital and American Hospital between June 2021, six months after the vaccination started, and December 2021...
June 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38628848/impact-of-influenza-related-hospitalization-in-spain-characteristics-and-risk-factor-of-mortality-during-five-influenza-seasons-2016-to-2021
#4
JOURNAL ARTICLE
José-Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Pilar González-de-la-Aleja, José Sánchez-Payá, Sergio Reus, Juan-Carlos Rodríguez-Díaz, Esperanza Merino
BACKGROUND: Estimating the global influenza burden in terms of hospitalization and death is important for optimizing prevention policies. Identifying risk factors for mortality allows for the design of strategies tailored to groups at the highest risk. This study aims to (a) describe the clinical characteristics of hospitalizations with a diagnosis of influenza over five flu seasons (2016-2017 to 2020-2021), (b) assess the associated morbidity (hospitalization rates and ICU admissions rate), mortality and cost of influenza hospitalizations in different age groups and (c) analyze the risk factors for mortality...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38618396/nephrotic-syndrome-due-to-sunitinib-a-rare-complication-of-treatment-of-renal-cell-carcinoma
#5
Sunny Malde, Pranjal Kashiv, Sushrut Gupta, Shubham Dubey, Manish Balwani, Amit Pasari, Kapil N Sejpal, Prasad Gurjar
This case report details a 62-year-old male with a history of right renal cell carcinoma (RCC) who developed sunitinib-induced nephrotic syndrome during treatment. The patient had a complex medical history, including a right nephrectomy in 2009, brain metastasis excisions in 2011 and 2012, and prolonged sunitinib therapy. Hypothyroidism, hypertension, and various surgeries further complicated his clinical picture. In April 2022, the patient presented with bilateral pedal edema, acute kidney injury superimposed on chronic kidney disease, and proteinuria...
March 2024: Curēus
https://read.qxmd.com/read/38606791/molecular-and-pathophysiological-relationship-between-obesity-and-chronic-inflammation-in-the-manifestation-of-metabolic-dysfunctions-and-their-inflammation%C3%A2-mediating-treatment-options-review
#6
REVIEW
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis-Nobelos
Obesity reaches up to epidemic proportions globally and increases the risk for a wide spectrum of co‑morbidities, including type‑2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular diseases, non‑alcoholic fatty liver disease, kidney diseases, respiratory disorders, sleep apnea, musculoskeletal disorders and osteoarthritis, subfertility, psychosocial problems and certain types of cancers. The underlying inflammatory mechanisms interconnecting obesity with metabolic dysfunction are not completely understood...
June 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38603695/development-of-a-prognostic-risk-score-to-predict-early-mortality-in-incident-elderly-japanese-hemodialysis-patients
#7
JOURNAL ARTICLE
Hirokazu Okada, Atsushi Ono, Koji Tomori, Tsutomu Inoue, Norio Hanafusa, Ken Sakai, Ichiei Narita, Toshiki Moriyama, Yoshitaka Isaka, Kei Fukami, Seiji Itano, Eiichiro Kanda, Naoki Kashihara
BACKGROUND: Information of short-term prognosis after hemodialysis (HD) introduction is important for elderly patients with chronic kidney disease (CKD) and their families choosing a modality of renal replacement therapy. Therefore, we developed a risk score to predict early mortality in incident elderly Japanese hemodialysis patients. MATERIALS AND METHODS: We analyzed data of incident elderly HD patients from a nationwide cohort study of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) to develop a prognostic risk score...
2024: PloS One
https://read.qxmd.com/read/38602847/nascent-shifts-in-renal-cellular-metabolism-structure-and-function-due-to-chronic-empagliflozin-in-prediabetic-mice
#8
JOURNAL ARTICLE
Blythe D Shepard, Jennifer Chau, Ryan Kurtz, Avi Z Rosenberg, Pinaki Sarder, Samuel P Border, Brandon Ginley, Olga Rodriguez, Chris Albanese, Grace Knoer, Aarenee Greene, Aline M A De Souza, Suman Ranjit, Moshe Levi, Carolyn M Ecelbarger
Sodium-glucose cotransporter, type 2 inhibitors (SGLT2i) are emerging as the gold standard for treatment of type 2 diabetes (T2D) with renal protective benefits independent of glucose lowering. We took a high-level approach to evaluate the effects of the SGLT2i, empagliflozin (EMPA) on renal metabolism and function in a prediabetic model of metabolic syndrome. Male and female 12-wk-old TallyHo (TH) mice, and their closest genetic lean strain (Swiss-Webster, SW) were treated with a high-milk-fat diet (HMFD) plus/minus EMPA (@0...
April 1, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38598982/charmm-gui-membrane-builder-for-oxidized-phospholipid-membrane-modeling-and-simulation
#9
REVIEW
Turner P Brown, Dane E Santa, Brett A Berger, Lingyang Kong, Nathan J Wittenberg, Wonpil Im
Oxidative stress leads to the production of oxidized phospholipids (oxPLs) that modulate the biophysical properties of phospholipid monolayers and bilayers. As many immune cells are responsible for surveilling cells and tissues for the presence of oxPLs, oxPL-dependent mechanisms have been suggested as targets for treating chronic kidney disease, atherosclerosis, diabetes, and cancer metastasis. This review details recent experimental and computational studies that characterize oxPLs' behaviors in various monolayers and bilayers...
April 9, 2024: Current Opinion in Structural Biology
https://read.qxmd.com/read/38595915/unveiling-the-anticancer-effects-of-sglt-2i-mechanisms-and-therapeutic-potential
#10
REVIEW
Min Sun, Jilei Sun, Wei Sun, Xiaonan Li, Zhe Wang, Liwei Sun, Yuehui Wang
Cancer and diabetes are significant diseases that pose a threat to human health. Their interconnection is complex, particularly when they coexist, often necessitating multiple therapeutic approaches to attain remission. Sodium-glucose cotransporter protein two inhibitors (SGLT-2i) emerged as a treatment for hyperglycemia, but subsequently exhibited noteworthy extra-glycemic properties, such as being registered for the treatment of heart failure and chronic kidney disease, especially with co-existing albuminuria, prompting its assessment as a potential treatment for various non-metabolic diseases...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38593462/high-incidence-of-antibiotic-resistance-in-the-uropathogenic-bacteria-associated-with-different-urological-diseases-and-metabolic-complications-a-single-center-cross-sectional-study
#11
JOURNAL ARTICLE
Yuvarajan Subramaniyan, Altaf Khan, M Mujeeburahiman, Punchappady Devasya Rekha
Urological diseases affect all age groups and are associated with different urinary complications. Presence of pathogenic bacteria complicates the urological diseases such as chronic kidney disease (CKD), kidney stone disease (KSD), emphysematous pyelonephritis (EPN), and urological cancers (UCs) coinciding with urinary metabolic complications. The One Health concept for preventing the spread of antibiotic resistant opportunistic pathogens necessitates detailed investigation on the virulence and the antibiotic sensitivity patterns of the pathogens from the urinary tract infections (UTIs)...
April 8, 2024: Microbial Drug Resistance: MDR: Mechanisms, Epidemiology, and Disease
https://read.qxmd.com/read/38592013/optimizing-care-delivery-in-patients-with-chronic-kidney-disease-in-the-united-states-proceedings-of-a-multidisciplinary-roundtable-discussion-and-literature-review
#12
REVIEW
Jamie S Hirsch, Samuel Colby Danna, Nihar Desai, Ty J Gluckman, Manisha Jhamb, Kim Newlin, Bob Pellechio, Ahlam Elbedewe, Evan Norfolk
BACKGROUND: Approximately 37 million individuals in the United States (US) have chronic kidney disease (CKD). Patients with CKD have a substantial morbidity and mortality, which contributes to a huge economic burden to the healthcare system. A limited number of clinical pathways or defined workflows exist for CKD care delivery in the US, primarily due to a lower prioritization of CKD care within health systems compared with other areas (e.g., cardiovascular disease [CVD], cancer screening)...
February 20, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38586590/clinical-outcomes-following-discontinuation-of-metformin-in-patients-with-type-2-diabetes-and-advanced-chronic-kidney-disease-in-hong-kong-a-territory-wide-retrospective-cohort-and-target-trial-emulation-study
#13
JOURNAL ARTICLE
Aimin Yang, Mai Shi, Hongjiang Wu, Eric Sh Lau, Johnny Tk Cheung, Xinge Zhang, Baoqi Fan, Tingting Chen, Alice Ps Kong, Andrea Oy Luk, Ronald Cw Ma, Juliana Cn Chan, Elaine Chow
BACKGROUND: Current labelling advises discontinuation of metformin when estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73 m2 due to increased risk of lactic acidosis. However, in real-world practice, the risk-benefit ratios remain uncertain. We examined the risk associations of discontinued-metformin use with cardiorenal and clinical outcomes in patients with type 2 diabetes (T2D) and advanced chronic kidney disease. METHODS: In this territory-wide, retrospective cohort and target trial emulation study, we included Chinese patients attending the Hong Kong Hospital Authority (HA) and enrolled in the Risk-Assessment-and-Management-Programme-for-Diabetes-Mellitus (RAMP-DM) from 2002 to 2019...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38586465/interaction-between-anemia-and-hyperuricemia-in-the-risk-of-all-cause-mortality-in-patients-with-chronic-kidney-disease
#14
JOURNAL ARTICLE
Zhaoxuan Lu, Fangping Lu, Ruixue Zhang, Shuting Guo
AIM: Both hyperuricemia and anemia are not only the manifestation of chronic kidney disease (CKD) but also related to its occurrence and development. A recent study has found that there was a synergetic effect between hyperuricemia and anemia on new-onset CKD. Herein we aimed to explore the roles of hyperuricemia and anemia in the all-cause mortality in patients with CKD. METHODS: Data of adult patients with CKD were extracted from the National Health and Nutrition Examination Surveys (NHANES) database in 2009-2018 in this retrospective cohort study...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38580568/pediatric-kidney-transplantation-cancer-and-cancer-risk
#15
REVIEW
Kaitlyn E Order, Nancy M Rodig
Children with end-stage kidney disease (ESKD) face a lifetime of complex medical care, alternating between maintenance chronic dialysis and kidney transplantation. Kidney transplantation has emerged as the optimal treatment of ESKD for children and provides important quality of life and survival advantages. Although transplantation is the preferred therapy, lifetime exposure to immunosuppression among children with ESKD is associated with increased morbidity, including an increased risk of cancer. Following pediatric kidney transplantation, cancer events occurring during childhood or young adulthood can be divided into two broad categories: post-transplant lymphoproliferative disorders and non-lymphoproliferative solid tumors...
April 4, 2024: Seminars in Nephrology
https://read.qxmd.com/read/38579479/quantifying-depressive-symptoms-on-incidence-of-common-chronic-diseases-and-multimorbidity-patterns-in-middle-aged-and-elderly-chinese-adults
#16
JOURNAL ARTICLE
Liping Shao, Xiaohong Zhu, Dan-Lin Li, Luying Wu, Xujia Lu, Yulong Fan, Zhengpeng Qiao, Liying Hou, Chen-Wei Pan, Chaofu Ke
BACKGROUND: Depressive symptoms are highly prevalent and increase risks of various morbidities. However, the extent to which depressive symptoms could account for incidence of these chronic conditions, in particular multimorbidity patterns, remains to be examined and quantified. METHODS: For this cohort analysis, we included 9024-14,093 participants aged 45 years and older from the China Health and Retirement Longitudinal Study (CHARLS). Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the longitudinal associations between depressive symptoms and 13 common chronic diseases and 4 multimorbidity patterns...
March 23, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38576398/trends-in-the-prevalence-of-multiple-chronic-conditions-among-us-adults-with-hypertension-from-1999-2000-through-2017-2020
#17
JOURNAL ARTICLE
Chibuike J Alanaeme, Lama Ghazi, Oluwasegun P Akinyelure, Ying Wen, Ashley Christenson, Bharat Poudel, Erin E Dooley, Ligong Chen, Shakia T Hardy, Kathryn Foti, C Barrett Bowling, Michelle T Long, Lisandro D Colantonio, Paul Muntner
BACKGROUND: The prevalence of many chronic conditions has increased over the past several decades among US adults. Many adults with hypertension have other chronic conditions. METHODS: We estimated changes in the age-adjusted prevalence of multiple (≥3) chronic conditions, not including hypertension, using data from the National Health and Nutrition Examination Survey, from 1999-2000 to 2017-2020, among US adults with and without hypertension (24,851 and 24,337 participants, respectively)...
April 5, 2024: American Journal of Hypertension
https://read.qxmd.com/read/38576236/clinically-undiagnosed-diseases-in-autopsies-frequency-and-risk-factors
#18
JOURNAL ARTICLE
Umberto Maccio, Christoph Andreas Meier, Michael Reinehr, Frank Ruschitzka, Reto Schüpbach, Holger Moch, Zsuzsanna Varga
CONTEXT.—: Autopsies can reveal clinically undiagnosed diseases. However, the frequency of first diagnoses at autopsy and their association with clinically known risk factors are not well understood because of lack of systematic analyses addressing this topic. OBJECTIVE.—: To perform a large retrospective cohort analysis on the frequency of clinically undiagnosed postmortem findings and correlate these with patients' risk factors. DESIGN...
April 5, 2024: Archives of Pathology & Laboratory Medicine
https://read.qxmd.com/read/38572526/decreased-risk-of-renal-cell-carcinoma-in-patients-with-type-2-diabetes-treated-with-sodium-glucose-cotransporter-2-inhibitors
#19
JOURNAL ARTICLE
Chun-Huei Chiu, Wei-Yao Wang, Hung-Yi Chen, Pei-Lun Liao, Gwo-Ping Jong, Tsung-Yuan Yang
Patients with type 2 diabetes (T2D) are at a higher risk of developing renal cell carcinoma (RCC) than the general population. In vitro and in vivo investigations of the effects of sodium glucose cotransporter-2 inhibitors (SGLT2I) have shown a significantly reduced risk of RCC. However, the impact of these drugs on the incidence of RCC in the human population is unclear. This study aimed to examine the association between SGLT2I use and RCC risk in patients with T2D. We undertook a nationwide retrospective cohort study using the Health and Welfare Data Science Center database (2016-2020)...
April 4, 2024: Cancer Science
https://read.qxmd.com/read/38567745/acute-kidney-injury-after-robot-assisted-laparoscopic-prostatectomy-a-meta-analysis
#20
JOURNAL ARTICLE
Deepak Chandramohan, Raghunandan Konda, Ashwini Pujari, Sreekant Avula, Sujith Kumar Palleti, Nihar Jena, Roopa Naik, Atul Bali
BACKGROUND: We investigated the rates of acute kidney injury (AKI) post robot-assisted laparoscopic prostatectomy (RALP). METHODS: A comprehensive search was conducted to identify studies that reported the rates of AKI post-RALP. A random effects model was used, and the pooled rates of AKI were calculated. RESULTS: We identified 10 studies with 60,937 patients to be included. The mean age was 65.1 years. The mean anaesthesia time was 234...
April 2024: International Journal of Medical Robotics + Computer Assisted Surgery: MRCAS
keyword
keyword
83470
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.